Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

Progress in Detection of CirculatingTumor Cell byin vivo Photoacoustic Flow Cytometry

Noninvasive and Label-Free Detection of Circulating Melanoma Cells by in Vivo Photoacoustic Flow Cytometry

In vivo, label-free, and noninvasive detection of melanoma metastasis by photoacoustic flow cytometry

Improving the Signal Analysis for in Vivo Photoacoustic Flow Cytometry

Label-free counting of circulating cells by in vivo photoacoustic flow cytometry

Photoacoustic Signal Classification for in Vivo Photoacoustic Flow Cytometry Based on Support Vector Machine

Label-free Counting of Circulating Melanoma Cells in Deep Vessels with Photoacoustic Flow Cytometry

In Vivo Dynamic Monitoring of Circulating Melanoma Cells and the Inhibitory Effect of PD-L1 Inhibitor Based on PAFC Equipped with a Deep Learning Framework

A Noninvasive and Real-Time Method for Circulating Tumor Cell Detection by In Vivo Flow Cytometry.

In vivo photoacoustic flow cytometry‐based study of the effect of melanin content on melanoma metastasis

Advances of In Vivo Flow Cytometry on Cancer Studies

A Model for the Detection of Circulating Tumor Cells Based on Micro-OCT Imaging

Monitoring circulating tumor cells in vivo by a confocal microscopy system

A Novel Approach to Harnessing Acoustic A-Lines to Detect Circulating Tumor Cells in Flowing Blood

In vivo flow cytometry: A powerful optical technology to detect circulating tumor cells and diagnose cancer metastasis in vivo/In-vivo-Durchflusszytometrie: Ein leistungsstarkes optisches Verfahren zur Detektion zirkulierender Tumorzellen und zur In-vivo-Diagnose von Metastasen

Application of Convolutional Neural Network in Signal Classification for in Vivo Photoacoustic Flow Cytometry

Detection of circulating tumor cells: opportunities and challenges

New Advancements in the Detection of Circulating Tumor Cells

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Current Detection Technologies for Circulating Tumor Cells.

Detection Of Circulating Tumor Cells And Circulating Tumor Stem Cells In Breast Cancer By Using Flow Cytometry